Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Sensitizing tumor cells to immune-mediated cytotoxicity.

Sensitizing tumor cells to immune-mediated cytotoxicity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Sensitizing tumor cells to immune-mediated cytotoxicity. Abstract Text:

    anil shankerAnil Shanker,thomas sayersThomas Sayers,

    The molecular basis underlying tumor destruction in vivo by specific antitumor CD8+ T cells remains unclear. We propose that the local production of certain tumor necrosis factor (TNF)-family members (death ligands) may be more important for tumor destruction in vivo than previously thought. Also, the apoptotic response of some tumor cells to the TNF-family member TRAIL can be augmented by the proteasome inhibitor bortezomib (Velcade). Thus, bortezomib may sensitize tumor cells to T cell-mediated cytotoxicity and could potentially improve the beneficial effects of immunotherapy.

    Sensitizing tumor cells to immune-mediated cytotoxicity. Publishing Authors By Initials

    a shankerA Shanker,t sayersT Sayers,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: monokines: tumor necrosis factor-alpha research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: monokines: tumor necrosis factor-alpha research

    PUBMED ID PMID:

    MEDLINE DATE:

    Sensitizing tumor cells to immune-mediated cytotoxicity. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Advances in experimental medicine and biology

    VOLUME: 601

    Page Numbers: 163-71

    Journal Abbreviation: Adv. Exp. Med. Biol.

    ISSN: 0065-2598

    DAY: 3

    MONTH: 12

    YEAR: 2007

    Sensitizing tumor cells to immune-mediated cytotoxicity. Information

    Number of References: 18

    LANGUAGE: eng

    NlmUniqueID: 121103

    Sensitizing tumor cells to immune-mediated cytotoxicity. Keywords Mesh Terms:

    KEYWORDS: Tumor Necrosis Factor-alpha

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Sensitizing tumor cells to immune-mediated cytotoxicity. Information

    Substance Name: Proteasome Endopeptidase Complex

    Registry Number: EC 3.4.25.1

    Grant and Affiliation Information for Sensitizing tumor cells to immune-mediated cytotoxicity.

    AFFILIATION: Cancer and Inflammation Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: N01-CO-12400

    ACRONYM: CO

    MEDLINETA: Adv Exp Med Biol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Sensitizing tumor cells to immune-mediated cytotoxicity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News